---
title: "Hong Kong stock pharmaceutical stocks rebound, OCUMENSION-B rises nearly 12%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/256050989.md"
description: "As of the time of publication, OCUMENSION-B rose by 11.99%, IMMUNEONCO-B rose by 10.73%, KEYMED BIO-B rose by 8.61%, and CANBRIDGE-B rose by 6.79%"
datetime: "2025-09-05T03:01:32.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/256050989.md)
  - [en](https://longbridge.com/en/news/256050989.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/256050989.md)
---

# Hong Kong stock pharmaceutical stocks rebound, OCUMENSION-B rises nearly 12%

As of the time of publication, OCUMENSION-B is up 11.99%, IMMUNEONCO-B is up 10.73%, KEYMED BIO-B is up 8.61%, and CANBRIDGE-B is up 6.79%

### Related Stocks

- [01477.HK](https://longbridge.com/en/quote/01477.HK.md)
- [02162.HK](https://longbridge.com/en/quote/02162.HK.md)
- [01228.HK](https://longbridge.com/en/quote/01228.HK.md)
- [01541.HK](https://longbridge.com/en/quote/01541.HK.md)

## Related News & Research

- [CATL explores potential $5 billion Hong Kong share sale after stock rally, sources say](https://longbridge.com/en/news/282657533.md)
- [PegBio Wins China Nod for Hong Kong Share Full Circulation](https://longbridge.com/en/news/282277506.md)
- [OKX Ventures, HashKey back VPBank-linked CAEX for Vietnam crypto pilot push](https://longbridge.com/en/news/282277796.md)
- [09:08 ETCoffee tops Americans' beverage choices](https://longbridge.com/en/news/282697733.md)
- [<![CDATA[Amgen’s Tarlatamab Approved in China ]]>](https://longbridge.com/en/news/282355594.md)